(Q36672092)

15 August 2017

1 reference

title

Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals (English)

1 reference

15 August 2017

Rice WG

1

1 reference

PubMed ID

7495676

15 August 2017

Bader JP

series ordinal

2

1 reference

15 August 2017

1 January 1995

1 reference

15 August 2017

Advances in Pharmacology

1 reference

15 August 2017

33

1 reference

15 August 2017

389-438

1 reference

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Potential metal-binding domains in nucleic acid binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A bioassay for HIV-1 based on Env-CD4 interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A rapid in vitro assay for HIV DNA integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Regulation of human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Human immunodeficiency virus uses tRNA(Lys,3) as primer for reverse transcription in HeLa-CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The HIV-1 protease as a therapeutic target for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV inhibitors targeted at the reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV resistance to reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Review article initial stages in infection with animal viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Changes in the host range and growth potential of an HIV-1 clone are conferred by the vpu gene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Cell-free transmission of Vif mutants of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibitors of human immunodeficiency virus integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Dextran sulfate disposition in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Binding characteristics of Rauscher leukemia virus envelope glycoprotein gp71 to murine lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

RNA recognition by the human immunodeficiency virus Tat and Rev proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Cellular transcription factors involved in the regulation of HIV-1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A detailed model of reverse transcription and tests of crucial aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Genetics of retroviral integration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A semiautomated multiparameter approach for anti-HIV drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A novel assay for the DNA strand-transfer reaction of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Derivation of a biologically contained replication system for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Drug therapy. Treatment of herpesvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Role of vif during packing of the core of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A radiometric assay for HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Animal models for anti-AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Dextran sulfate is poorly absorbed after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Novel indolocarbazole protein kinase C inhibitors prevent reactivation of HIV-1 in latently infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Mechanism of DNA Strand Transfer Reactions Catalyzed by HIV-1 Reverse Transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of Human Immunodeficiency Virus (HTV-1) Replication In Vitro by Noncytotoxic Doses of Camptothecin, a Topoisomerase I Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV regulatory proteins: potential targets for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The CD4 antigen: physiological ligand and HIV receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Searching for pharmacophores in large coordinate data bases and its use in drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Structure-based discovery of inhibitors of thymidylate synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of glycoprotein processing and HIV replication by castanospermine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A fluorometric assay for HIV-protease activity using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

Regulation of HIV-1 gag protein subcellular targeting by protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960675-4

7 January 2021

10.1016/S1054-3589(08)60675-4

Identifiers

DOI

0 references

PubMed ID

7495676

1 reference

PubMed ID

7495676